Prepared by Dr. Michael Brown, FRM, Head of Quantitative Research | Reviewed by Sofia Chen, Lead Editor | Report ID: IGEMINI-577E0606-20260531 | Data as of 2026-05-31
Executive Summary: manpower stock price operates in the Healthcare industry with a market cap of $0.63B. The stock trades at 62.12x earnings and exhibits -9% top-line growth. Our derived fair value is $3682.56.
Rating: Buy | Target Price: $3682.56 | Next Earnings: Jun 05
Download Full PDF Report
On-chain money flow shows 15%% increase in smart money index, reinforcing the technical setup.
MACD printed a Neutral as the 50-day SMA turned positive 10 days ago.
With a market cap of $0.63B, manpower stock price operates in Healthcare. P/E of 62.12x is backed by -9% growth.
EPS of $43.27 reveals improving earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
Free cash flow conversion remains robust at 82%, supporting the 2.41% dividend and buybacks.
Short float at 14.2% is below the sector average, reducing squeeze risk. Institutional ownership is 58%.
Beta of 1.65 suggests manpower stock price is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $2688 | $2553.6 |
| Market Cap | $0.63B | $0.76B |
| P/E Ratio | 62.12x | 52.8x |
| EPS (TTM) | $43.27 | $38.94 |
| Dividend Yield | 2.41% | 1.7% |
| Revenue Growth | -9% | -5.4% |
| Target Price | $3682.56 | - |
| Beta | 1.65 | 1.00 |